List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 88 studies with search of: Open Studies | "Diabetic Retinopathy"
Include studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Unknown † Bevacizumab Versus Ranibizumab for Diabetic Retinopathy
Conditions: Diabetic Retinopathy;   Diabetic Macula Edema;   Proliferative Diabetic Retinopathy
Interventions: Drug: bevacizumab;   Drug: Ranibizumab
2 Recruiting Topical Application of Latanoprost in Diabetic Retinopathy
Condition: Diabetic Retinopathy
Intervention: Drug: Latanoprost
3 Unknown † Intravitreal Bevacizumab Vs Photocoagulation for Proliferative Diabetic Retinopathy
Condition: Diabetic Retinopathy
Interventions: Drug: intravitreal injection of bevacizumab;   Procedure: panretinal photocoagulation
4 Recruiting Trientine Hydrochloride for the Prevention of Macular Edema Associated With Pan-retinal Photocoagulation for Severe Non-proliferative and Proliferative Diabetic Retinopathy
Condition: Diabetic Retinopathy
Interventions: Drug: Trientine Hydrochloride;   Drug: Oral placebo capsules
5 Recruiting Genetic Association of Diabetic Retinopathy-1
Conditions: Diabetes;   Diabetic Retinopathy
Intervention:
6 Recruiting Propranolol for Diabetic Retinopathy
Condition: Proliferative Diabetic Retinopathy
Intervention: Drug: Propranolol
7 Recruiting Panretinal Photocoagulation for Diabetic Retinopathy With PASCAL Laser
Condition: Diabetic Retinopathy
Intervention: Procedure: Panretinal photocoagulation
8 Recruiting Avastin for PDR (Proliferative Diabetic Retinopathy)
Conditions: Retinal Detachment;   Diabetic Retinopathy
Interventions: Drug: Avastin (bevacizumab);   Other: Sham injection
9 Recruiting Topic Ketorolac Added to Panphotocoagulation in Proliferative Diabetic Retinopathy
Conditions: Proliferative Diabetic Retinopathy;   Macular Edema
Interventions: Drug: Tromethamine ketorolac;   Drug: Alcohol polivinilico
10 Unknown † Trial of Yellow 577 nm Laser Versus Green 532 nm Laser for Proliferative Diabetic Retinopathy
Condition: Proliferative Diabetic Retinopathy
Intervention: Procedure: Pan retinal photocoagulation laser treatment
11 Recruiting Safety and Efficacy of Intravitreal Ranibizumab as a Preoperative Adjunct Treatment Before Vitrectomy Surgery in Proliferative Diabetic Retinopathy (PDR) Compared to Vitrectomy Alone
Condition: Diabetic Retinopathy
Interventions: Drug: ranibizumab and vitrectomy;   Procedure: vitrectomy without preoperative ranibizumab
12 Recruiting Bevacizumab as Adjunctive Treatment to Laser Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Condition: Proliferative Diabetic Retinopathy
Interventions: Procedure: Panretinal photocoagulation;   Procedure: Procedure: Panretinal Photocoagulation (PRP) Drug: Intravitreous injection of Bevacizumab
13 Unknown † Evaluation of Ranibizumab in Proliferative Diabetic Retinopathy (PDR) Requiring Vitrectomy
Condition: Proliferative Diabetic Retinopathy
Intervention: Drug: Lucentis (ranibizumab)
14 Recruiting Prospective, Randomized, Multicenter, Open Label, Phase II Study to Access Efficacy and Safety of Lucentis® Monotherapy Compared With Lucentis® Plus Panretinal Photocoagulation (PRP) and PRP in the Treatment of Patients With High Risk Proliferative Diabetic Retinopathy
Condition: High Risk Proliferative Diabetic Retinopathy
Interventions: Procedure: Panretinal Photocoagulation (PRP);   Drug: Intravitreous injection of ranibizumab
15 Recruiting Prospective, Randomized, Open Label, Phase II Study to Assess Efficacy and Safety of Macugen® (Pegaptanib 0.3 mg Intravitreal Injections) Plus Panretinal Photocoagulation (PRP) and PRP (Monotherapy) in the Treatment of Patients With High Risk Proliferative Diabetic Retinopathy (PDR).
Conditions: High Risk Proliferative Diabetic Retinopathy;   Diabetes Mellitus Type I;   Diabetes Mellitus Type II
Interventions: Procedure: Panretinal Photocoagulation (PRP);   Drug: Intravitreous injection of pegaptanib
16 Unknown † Changes in Electroretinogram and Contrast Sensitivity After PASCAL Treatment
Conditions: Non Proliferative Diabetic Retinopathy;   Proliferative Diabetic Retinopathy
Intervention: Procedure: PASCAL laser treatment
17 Recruiting Macular Tractional Retinoschisis in Proliferative Diabetic Retinopathy
Condition: Proliferative Diabetic Retinopathy
Intervention:
18 Not yet recruiting Diabetic Retinopathy in HIV Subjects Treated With EGRIFTA®
Conditions: Diabetic Retinopathy;   HIV
Interventions: Drug: Tesamorelin;   Drug: Placebo-Control
19 Recruiting Vitrous Analysis in Proliferative Diabetic Retinopathy
Condition: Proliferative Diabetic Retinopathy
Intervention:
20 Unknown † Study Investigating the Levels and Effects of Low-grade Inflammation in Diabetic Retinopathy of Type 1 Diabetes
Conditions: Diabetic Retinopathy;   Inflammation
Interventions: Procedure: Blood sampling;   Procedure: Noninvasive measurement of systemic hemodynamics;   Procedure: Visual acuity assessment;   Device: Blue field entoptic technique (Blue field stimulator, BFS-2050);   Procedure: Ophthalmic examination and fundus photography;   Device: Retinal Vessel Analyzer (DVA);   Device: High resolution optical coherence tomography (OCT)

Previous Page Studies Shown (1-20) Next Page (21-40)
† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services